Oncology & Cancer

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer, according to new research funded by Cancer Research UK published today.

Medications

Statins may lower mortality in high-risk prostate cancer patients

Among high-risk prostate cancer patients—those with high PSA and Gleason scores of 8 or more—many will develop a difficult-to-treat disease. Preliminary research suggests that two commonly prescribed medications, cholesterol-lowering ...

Cardiology

Improving cardiovascular health of the most vulnerable

Starting in 2016, a two-year partnership between the North Carolina Chapter of the American College of Cardiology (NCACC) and the North Carolina Association of Free and Charitable Clinics (NCAFCC) provided free lipid lowering ...

Oncology & Cancer

Statins may do double duty on heart disease and cancer

About 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease. They might also be getting an added anti-cancer benefit, a growing body of evidence suggests.

Cardiology

Risk for skin infections, diabetes increase with statin use

(HealthDay)—Using statins for as short a time as three months can put patients at risk for developing diabetes and skin and soft tissue infections (SSTIs), according to a study published in the November issue of the British ...

page 15 from 40